Sfoglia per Autore
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy
2008 G. Melli, M. Taiana, F. Camozzi, D. Triolo, P. Podini, A. Quattrini, F. Taroni, G. Lauria
Morphometry of dermal nerve fibers in human skin
2011 G. Lauria, D. Cazzato, C. Porretta-Serapiglia, J. Casanova-Molla, M. Taiana, P. Penza, R. Lombard, C..G. Faber, I..S..J. Merkies
Side and time variability of intraepidermal nerve fiber density
2015 G. LAURIA PINTER, P. Dacci, R. Lombardi, D. Cazzato, M.M. Taiana, J. Sassone, E. Dalla Bella, S. Rinaldo, C. Lettieri, R. Eleopra, G. Devigili
ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin
2016 J. Sassone, M.M. Taiana, R. Lombardi, C. Porretta Serapiglia, M. Freschi, S. Bonanno, S. Marcuzzo, F. Caravello, C. Bendotti, G. LAURIA PINTER
Mutant SOD1 accumulation in sensory neurons does not associate with endoplasmic reticulum stress features: Implications for differential vulnerability of sensory and motor neurons to SOD1 toxicity
2016 M.M. Taiana, J. Sassone, G. LAURIA PINTER
Network topology of NaV1.7 mutations in sodium channel-related painful disorders
2017 D. Kapetis, J. Sassone, Y. Yang, B. Galbardi, M.N. Xenakis, R.L. Westra, R. Szklarczyk, P. Lindsey, C.G. Faber, M. Gerrits, I.S.J. Merkies, S.D. Dib-hajj, M. Mantegazza, S.G. Waxman, G. LAURIA PINTER, M.M. Taiana, M. Marchi, R. Lombardi, D. Cazzato, F. Boneschi Martinelli, A. Zauli, F. Clarelli, S. Santoro, I. Lopez, A. Quattrini, J. Hoeijmakers, M. Sopacua, B. De Greef, H.J.M. Smeets, R. Al Momani, J.M. Vanoevelen, I. Eijkenboom, S. Cestãle, O. Chever, R. Malik, M. Tavakoli, D. Ziegler, F. MARTINELLI BONESCHI
COL6A5 variants in familial neuropathic chronic itch
2017 F. Martinelli Boneschi, M. Colombi, M. Castori, G. Devigili, R. Eleopra, R.A. Malik, M. Ritelli, N. Zoppi, C. Dordoni, M. Sorosina, P. Grammatico, H. Fadavi, M.M. Gerrits, R. Almomani, C.G. Faber, I.S.J. Merkies, D. Toniolo, M. Cocca, C. Doglioni, S.G. Waxman, S.D. Dib-hajj, M..M. Taiana, J. Sassone, R. Lombardi, D. Cazzato, A. Zauli, S. Santoro, M. Marchi, G. Lauria
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis
2017 V. Tosetti, J. Sassone, A.L.M. Ferri, M. Taiana, G. Bedini, S. Nava, G. Brenna, C. Di Resta, D. Pareyson, A.M. Di Giulio, S. Carelli, E.A. Parati, A. Gorio
R-Loops in Motor Neuron Diseases
2018 M.G.L. Perego, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2019 F. Rizzo, M. Nizzardo, S. Vashisht, E. Molteni, V. Melzi, M. Taiana, S. Salani, P. Santonicola, E. Di Schiavi, M. Bucchia, A. Bordoni, I. Faravelli, N. Bresolin, G.P. Comi, U. Pozzoli, S. Corti
IGHMBP2 related pathological pathways in Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1) in vitro models
2019 N. Galli, M. Taiana, E. Pagliari, S. Ghezzi, G. Comi, S. Corti, M. Nizzardo
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
2020 D. Gagliardi, G. Costamagna, M. Taiana, L. Andreoli, F. Biella, M. Bersani, N. Bresolin, G.P. Comi, S. Corti
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
2020 M.G.L. Perego, N. Galli, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
2020 M. Saladini, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
Evaluation of Morpholino oligomers therapeutic efficacy in C9orf72 ALS iPSC-derived lines
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, N. Bresolin, G.P. Comi, S. Corti
Optimization of AAV9 gene therapy for Spinal Muscular Atrophy with respiratory distress Type 1 using in vivo disease models
2020 E. Pagliari, P. Rinchetti, N. Galli, S. Ghezzi, M. Taiana, G. Comi, S. Corti, M. Nizzardo
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients
2021 C. Malacarne, M. Galbiati, E. Giagnorio, P. Cavalcante, F. Salerno, F. Andreetta, C. Cagnoli, M. Taiana, M. Nizzardo, S. Corti, V. Pensato, A. Venerando, C. Gellera, S. Fenu, D. Pareyson, R. Masson, L. Maggi, E. Dalla Bella, G. Lauria, R. Mantegazza, P. Bernasconi, A. Poletti, S. Bonanno, S. Marcuzzo
Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy
2021 N. Hensel, F. Cieri, P. Santonicola, I. Tapken, T. Schüning, M. Taiana, E. Pagliari, A. Joseph, S. Fischer, N. Heidrich, H. Brinkmann, S. Kubinski, A.K. Bergmann, M.F. Richter, K. Jung, S. Corti, E. Di Schiavi, P. Claus
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile